The U.S. National Institutes of Health (NIH) is highlighting new research opportunities in Digital Twins for Biomedical, Biological, and Behavioral Research, supporting innovative approaches to accelerate scientific discovery and advance healthcare technologies.
As the European Union moves forward with revising Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR), the European Parliament’s Committee on Environment, Public Health and Food Safety (SANT) is taking a central role in recalibrating the MedTech regulatory landscape.
The European Medicines Agency (EMA) has initiated a voluntary pilot testing a revised model for Pre-Submission Interactions (PSI) ahead of initial Marketing Authorisation Applications (MAAs).
On 3 September 2026, during the VPH Conference in Milan, VPH hosted a plenary roundtable "From Credibility to Trust".
The European Commission’s Joint Research Centre (JRC) played an active role in the VPH2026 Conference, held in Milan, bringing its expertise in computational modelling and in silico medicine to discussions on the future of healthcare.
Vall d’Hebron University Hospital launches €7.3 million tender to advance Digital Twins and AI for personalised healthcare
Upcoming Horizon Europe calls open new opportunities for collaboration across computational modelling, Virtual Human Twins, artificial intelligence and advanced biomedical technologies, areas of strong interest for the in silico medicine community.
This new Avicenna Alliance position paper, co-authored by Marc Horner, Ani Amar, Alejandro F. Frangi, Martha De Cunha Maluf-Burgman, Thierry Marchal and VPH Board of Director member, Francesco Pappalardo, describes a practical, risk-based framework to strengthen regulatory confidence and accelerate the adoption of in silico evidence.
VPH is hiring! Join our team to work at the interface of science, healthcare, industry and European policy to support the responsible adoption of emerging health technologies.
We are pleased to present the 2027 Board of Directors of the VPH Society, appointed during the recent GA in Milan to guide the Society’s strategic priorities and initiatives in the year ahead.
During the VPH2026 Conference, members of the VPH team presented original research exploring how emerging healthcare technologies are communicated, understood and integrated by healthcare professionals, the media and patients.
A record 650 participants gathered in Milan to exchange knowledge, foster collaboration and explore the future of in silico medicine.
